BackEdwards Lifesciences Overview
stock.name

Edwards Lifesciences Target Price

Analysts' 12-month price predictions for EW.

Share Price

$89.14

Average Target Price

$102.2514.7% upside

4 analysts in the last 4 months

High: $105 | Low: $100

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-05-14Deutsche BankPito Chickering$10315.5% upsideOpen
2024-04-15RBC CapitalShagun Singh$10113.3% upsideOpen
2024-04-11Mizuho SecuritiesAnthony Petrone$10517.8% upsideOpen
2024-03-18OppenheimerSuraj Kalia$10012.2% upsideOpen
2023-02-01Canaccord Genuity$7614.7% downsideOpen
2023-02-01Truist Financial$863.5% downsideOpen
2023-01-06Morgan Stanley$956.6% upsideOpen
2022-12-13Raymond James$836.9% downsideOpen
2022-12-12Citigroup$923.2% upsideOpen
2022-12-05Stifel NicolausRick Wise$7515.9% downsideOpen
2022-11-28RBC Capital$10517.8% upsideOpen
2022-10-28RBC CapitalShagun Singh Chadha$11832.4% upsideOpen
2022-07-30Truist FinancialRichard Newitter$12034.6% upsideOpen
2022-04-27Canaccord Genuity$13753.7% upsideOpen
2022-04-27Raymond James$12439.1% upsideOpen
2022-04-27RBC Capital$13551.4% upsideOpen
2022-04-27Leerink Partners$13854.8% upsideOpen
2022-04-06Evercore ISIVijay Kumar$12641.4% upsideOpen
2022-03-03Bank of America SecuritiesTravis Steed$13045.8% upsideOpen
2022-01-27Morgan StanleyCecilia Furlong$13652.6% upsideOpen
2022-01-27Leerink PartnersDanielle Antalffy$13045.8% upsideOpen
2022-01-27Stifel NicolausRick Wise$12034.6% upsideOpen
2022-01-26Deutsche BankPito Chickering$11326.8% upsideOpen
2022-01-07Credit SuisseMatt Miksic$14057.1% upsideOpen
2021-12-17J.P. MorganRobbie Marcus$14057.1% upsideOpen
2021-12-09OppenheimerSuraj Kalia$13551.4% upsideOpen
2021-12-09Cowen & Co.Josh Jennings$14057.1% upsideOpen
2021-12-09Wells FargoLarry Biegelsen$13349.2% upsideOpen
2021-11-08JefferiesAnthony Petrone$13551.4% upsideOpen